Bausch Health Companies (BHC) Current Deferred Tax Assets (2010 - 2015)
Bausch Health Companies (BHC) posted Current Deferred Tax Assets of $727.2 million for Q3 2015, up 2.22% sequentially from $711.4 million in Q2 2015, and up 129.84% YoY from $316.4 million in Q3 2014.
Bausch Health Companies (BHC) Current Deferred Tax Assets (2010 - 2015) Analysis & Trends
Bausch Health Companies has reported Current Deferred Tax Assets for 6 years, with the latest figure at $727.2 million in Q3 2015.
- Quarterly Current Deferred Tax Assets rose 129.84% year-over-year to $727.2 million in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $727.2 million (up 129.84% YoY) and the FY2014 annual result came in at $193.3 million, down 47.32% from the prior year.
- Current Deferred Tax Assets improved to $727.2 million in Q3 2015 per BHC's latest filing, from $711.4 million in the prior quarter.
- Over five years, Current Deferred Tax Assets peaked at $727.2 million in Q3 2015 and troughed at $77.5 million in Q3 2011.
- A 5-year average of $252.5 million and a median of $196.5 million in 2015 frame the typical range for Current Deferred Tax Assets.
- The sharpest annual moves came in 2011 and 2014: Current Deferred Tax Assets soared 540.48% in 2011, then slumped 47.32% in 2014.
- Over 5 years, Current Deferred Tax Assets stood at $148.5 million in 2011, then surged by 31.36% to $195.0 million in 2012, then soared by 88.15% to $366.9 million in 2013, then slumped by 47.32% to $193.3 million in 2014, then soared by 276.2% to $727.2 million in 2015.
- According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $727.2 million, $711.4 million, and $196.5 million for Q3 2015, Q2 2015, and Q1 2015 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Bausch Health Companies | 2.42 Bn | 586.38 Mn | 2.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 727.20 Mn |
| Sep 30, 2015 | 727.20 Mn |
| Jun 30, 2015 | 711.40 Mn |
| Jun 30, 2015 | 711.40 Mn |
| Dec 31, 2014 | 193.30 Mn |
| Dec 31, 2014 | 193.30 Mn |
| Sep 30, 2014 | 316.40 Mn |
| Sep 30, 2014 | 316.40 Mn |
| Jun 30, 2014 | 309.80 Mn |
| Jun 30, 2014 | 309.80 Mn |
| Mar 31, 2014 | 315.30 Mn |
| Mar 31, 2014 | 315.30 Mn |
| Dec 31, 2013 | 366.90 Mn |
| Dec 31, 2013 | 366.90 Mn |
| Sep 30, 2013 | 221.93 Mn |
| Sep 30, 2013 | 221.93 Mn |
| Jun 30, 2013 | 198.67 Mn |
| Jun 30, 2013 | 198.67 Mn |
| Mar 31, 2013 | 198.88 Mn |
| Mar 31, 2013 | 198.88 Mn |